Chinese herbal medicine for moyamoya disease
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a Chinese herbal formula called Qiqi Shengmai can help people with moyamoya disease, a condition that narrows blood vessels in the brain. It aims to see if the herbal treatment is safe and might improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You must have a diagnosis of moyamoya disease based on imaging tests.
- You must be willing to receive traditional Chinese medicine treatment.
- Your condition must fit a specific Chinese medicine pattern called 'liver-yang hyperactivity'.
- You cannot have had a stroke or mini-stroke in the last 6 weeks.
- You cannot be scheduled for brain bypass surgery or be in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
This study tests whether daily aspirin, a special physical therapy called remote ischemic conditioning (RIC), or both can slow down moyamoya disease, a condition that narrows brain blood vessels and increases stroke risk. Participating may help you manage your condition and possibly prevent it from getting worse.
This trial tests whether exosomes made from special stem cells can help people with Moyamoya disease who still have symptoms after surgery. It aims to improve blood flow to the brain and reduce future strokes.
This study tests if statins (cholesterol-lowering drugs) can help people with Moyamoya disease. The trial will follow patients who receive either surgery or standard care to see if adding a statin improves outcomes.
This study looks at why some people with moyamoya disease have trouble with thinking and memory. It may help find better ways to understand and treat these problems.
This study looks at how Moyamoya disease changes over time and what predicts outcomes. It uses approved brain imaging and, likely, thinking/memory tests to understand prognosis.
Hear when a new Moyamoya Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.